Zeliang Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Urology top 10%
Papers in
-
- Circular RNAs in diseases 6
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 5
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Chuize Kong (26 shared papers)Jianbin Bi (16 shared papers)Xiankui Liu (16 shared papers)Yuyan Zhu (14 shared papers)Nan Zhou (3 shared papers)Zhibiao Feng (3 shared papers)Meng Yu (5 shared papers)Yanping Shi (2 shared papers)
- Journals
- Urology (4 papers)Cancer Gene Therapy (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Oncology Reports (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zeliang Li
41 papers receiving 961 citations
Peers
Comparison fields: 5 of 102
- Cancer Research 435
- Urology 56
- Molecular Biology 560
- Electronic, Optical and Magnetic Materials 69
- Sensory Systems 14
Countries citing papers authored by Zeliang Li
This map shows the geographic impact of Zeliang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeliang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeliang Li more than expected).
Fields of papers citing papers by Zeliang Li
This network shows the impact of papers produced by Zeliang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeliang Li. The network helps show where Zeliang Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zeliang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 91 | |
| 2 | 2010 | 82 | |
| 3 | 2020 | 69 | |
| 4 | 2019 | 56 | |
| 5 | 2017 | 54 | |
| 6 | 2018 | 49 | |
| 7 | 2005 | 39 | |
| 8 | 2017 | 36 | |
| 9 | 2019 | 35 | |
| 10 | 2018 | 34 | |
| 11 | GAS5 functions as a ceRNA to regulate hZIP1 expression by sponging miR-223 in clear cell renal cell carcinoma. | 2018 | 33 |
| 12 | 2005 | 32 | |
| 13 | 2018 | 31 | |
| 14 | 2018 | 30 | |
| 15 | 2018 | 30 | |
| 16 | 2019 | 23 | |
| 17 | 2019 | 23 | |
| 18 | 2018 | 21 | |
| 19 | 2017 | 21 | |
| 20 | 2018 | 21 |
About Zeliang Li
Zeliang Li is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 43 papers that have together received 975 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers), Hormonal Regulation and Hypertension (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Renal cell carcinoma treatment (4 papers), RNA modifications and cancer (4 papers) and Urinary Bladder and Prostate Research (3 papers). The work is most often cited by research in Cancer Research (435 citations), Urology (56 citations), Molecular Biology (560 citations), Electronic, Optical and Magnetic Materials (69 citations) and Sensory Systems (14 citations). Zeliang Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chuize Kong, Jianbin Bi, Xiankui Liu, Yuyan Zhu, Nan Zhou, Zhibiao Feng, Meng Yu, Yanping Shi, Zhe Zhang and Xingwei Zhang. Their work appears in journals such as Urology, Cancer Gene Therapy, Urologic Oncology Seminars and Original Investigations, Oncology Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.